Accelerated Pharma (Accelerated Pharma) ROCE % : 0.00% (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Accelerated Pharma's annualized ROCE % for the quarter that ended in Mar. 2017 was 0.00%.

Accelerated Pharma ROCE % Historical Data

The historical data trend for Accelerated Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma ROCE % Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

ROCE %

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
ROCE %	Get a 7-Day Free Trial			-	-	-	-	-

Accelerated Pharma ROCE % Calculation

Accelerated Pharma's annualized ROCE % for the fiscal year that ended in Dec. 2016 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2016 )		(A: Dec. 2015 )		(A: Dec. 2016 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2016 )		(A: Dec. 2015 )		(A: Dec. 2016 )
	=	-3.096	/	( ( (0.766 - 5.196)	+	(0.147 - 5.339) )	/ 2 )
	=	-3.096	/	( (-4.43	+	-5.192)	/ 2 )
	=	-3.096	/	-4.811
	=	64.35 %

Accelerated Pharma's ROCE % of for the quarter that ended in Mar. 2017 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2017 )		(Q: Dec. 2016 )		(Q: Mar. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2017 )		(Q: Dec. 2016 )		(Q: Mar. 2017 )
	=	-1.444	/	( ( (0.147 - 5.339)	+	(0.198 - 5.961) )	/ 2 )
	=	-1.444	/	( ( -5.192	+	-5.763 )	/ 2 )
	=	-1.444	/	-5.4775
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2017) EBIT data.

Accelerated Pharma (NAS:ACCP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Accelerated Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines